Use of daptomycin in a pregnant patient with Staphylococcus aureus endocarditis

Annals of Pharmacotherapy

Volumn 44, Issue 4, 2010, Pages 746-749

  Stroup, Jeffrey S ^a   Wagner, James ^b   Badzinski, Terry ^c  

^a OKLAHOMA STATE UNIVERSITY   (United States)

^b OKLAHOMA STATE UNIVERSITY   (United States)

^c OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

Daptomycin; Endocarditis; Pregnancy; S. aureus

Indexed keywords

BRONCHODILATING AGENT; DAPTOMYCIN; DIPHENHYDRAMINE; FAMOTIDINE; LEVOFLOXACIN; NAFCILLIN; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ABSENCE OF SIDE EFFECTS; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL ENDOCARDITIS; CASE REPORT; CESAREAN SECTION; DRUG ABUSE; DRUG SAFETY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EMBOLISM; FEMALE; FEVER; HUMAN; INTENSIVE CARE UNIT; LABORATORY TEST; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; OXYGEN THERAPY; PREGNANT WOMAN; PRIORITY JOURNAL; RASH; SECOND TRIMESTER PREGNANCY; SEPSIS; THORAX RADIOGRAPHY; TONGUE SWELLING; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT DURATION; TRICUSPID VALVE;

ANTI-BACTERIAL AGENTS; DAPTOMYCIN; ENDOCARDITIS, BACTERIAL; FEMALE; FEVER; HEART VALVE DISEASES; HUMANS; INFANT, NEWBORN; LEUKOCYTE COUNT; MICROBIAL SENSITIVITY TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; STAPHYLOCOCCAL INFECTIONS; SUBSTANCE ABUSE, INTRAVENOUS; TRICUSPID VALVE; YOUNG ADULT;

EID: 77950619270     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1M650     Document Type: Article

References (13)

1. Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med 2001;345:1318-1330 DOI 10.1056/NEJMra010082
2. Cherubin CE, Sapira JD. The medical complications of drug addiction and the medical assessment of the intravenous drug user: 25 years later. Ann Intern Med 1993;119:1017-1028
3. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association - executive summary: endorsed by the Infectious Diseases Society of America. Circulation 2005;111:e394-e433. DOI 10.1161/CIRCULATIONHA.105.165564
4. Eisenstein BI. Treatment of staphylococcal infections with cyclic lipopeptides. Clin Microbiol Infect 2008;14(suppl 2):10-16 (Pubitemid 351167056)
5. Hair PI, Keam SJ. Daptomycin: a review of its use in the management of complicated skin and soft-tissue infections and Staphylococcus bacter- aemia. Drugs 2007;67:1483-1512 DOI 10.2165/00003495-200767100-00008 (Pubitemid 47028521)
6. Levine DP, Lamp KC. Daptomycin in the treatment of patients with infective endocarditis: experience from a registry. Am J Med 2007;120(10 suppl 1):S28-33
7. Segreti JA, Crank CW, Finney MS. Daptomycin for the treatment of gram-positive bacteremia and infective endocarditis: a retrospective case series of 31 patients. Pharmacotherapy 2006;26:347-352 DOI 10.1592/phco.26.3.347 (Pubitemid 43334674)
8. Fowler VG, Boucher HW, Corey GR, et al.; S. aureus Endocarditis and Bacteremia Study Group. Daptomycin versus standard therapy for bac- teremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 2006;355:653-665 DOI 10.1056/NEJMoa053783 (Pubitemid 44244536)
9. Product information. Cubicin (daptomycin). Lexington, MA: Cubist Pharmaceuticals, Inc., August 2008
10. Shea K, Hilburger E, Baroco A, Oldfield E. Successful treatment of van- comycin-resistant Enterococcus faecium pyelonephritis with daptomycin during pregnancy. Ann Pharmacother 2008;42:722-725 DOI 10.1345/aph.1K561 (Pubitemid 351619946)
11. Cunha BA, Hamid N, Kessler H, Parchuri S. Daptomycin cure after ce- fazolin treatment failure of methicillin-sensitive Staphylococcus aureus (MSSA) tricuspid valve acute bacterial endocarditis from a peripherally inserted central catheter (PICC) line. Heart Lung 2005;34:442-447
12. Rybak M, Lomaestro B, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 2009;66:82-98. DOI 10.2146/ajhp080434
13. Mortin LI, Li T, Van Praagh A, Zhang XX, Alder J. Daptomycin efficacy in a model of MSSA or MRSA hematogenous pulmonary infection in mice and rats (poster 304). Presented at: 42nd Annual Meeting of the Infectious Diseases Society of America, Boston, September 30-October 3, 2004